PINL:GRPOF - Post by User
Comment by
Chuck03on Jul 30, 2018 10:43am
56 Views
Post# 28384957
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't own shares. but I think this helps TBP
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't own shares. but I think this helps TBPAngry? I didn't use exclamation marks?
I am aware.
SmokinAces wrote: I wouldnt get angry Chuck, most people tend to short trials inbetween stage 2 and 3 for their lead products, as it's the most expensive stage of development. It requires alot of financing to keep those trials going. Subsequently, a successful late stage 3 trial, will have an adverse effect on shorters. I;m not sure why you are worried or angry. Its just time that TBP needs. Shorters will not doubt make money, while you guys wait for trial data. But once its released, again you won't be dissappointed. In the future, just relize that investing in pharma should be done 1.) Early Clincial stage 1 and 2.) Late stage 3. Anything in between is a shorters paradise. Hope that helps.